We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current BOLT market cap is 44.72M. The company's latest EPS is USD -1.8226 and P/E is -0.64.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 2.11M | 1.41M | 1.83M | 1.43M | 2.53M |
| Operating Income | -22.35M | -21.04M | -18.42M | -19.83M | -18.18M |
| Net Income | -21.76M | -20M | -16.98M | -18.06M | -16.26M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 231k | 1.26M | 5.73M | 7.88M |
| Operating Income | -49.18M | -92.79M | -90.32M | -76.2M |
| Net Income | -60.73M | -98.59M | -88.1M | -69.2M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 245.51M | 227.81M | 206.18M | 190.7M | 175.36M |
| Total Liabilities | 57.06M | 56.3M | 48.5M | 48.56M | 47.1M |
| Total Equity | 188.45M | 171.51M | 157.69M | 142.13M | 128.26M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 46.54M | 307.72M | 227.81M | 159.78M |
| Total Liabilities | 46.19M | 57.6M | 56.3M | 47.04M |
| Total Equity | -104.95M | 250.12M | 171.51M | 112.74M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -58.55M | -76.5M | -23.4M | -38.51M | -55.26M |
| Investing | 41.43M | 57.86M | 28.99M | 42.57M | 55.23M |
| Financing | 359k | 503k | N/A | 147k | 147k |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -47.31M | -57.07M | -76.5M | -69.53M |
| Investing | -20.59M | -232.2M | 57.86M | 71.04M |
| Financing | 39.6M | 311.11M | 503k | 253k |
| Market Cap | 44.72M |
| Price to Earnings Ratio | -0.64 |
| Price to Sales Ratio | 5.59 |
| Price to Cash Ratio | 4.07 |
| Price to Book Ratio | 0.39 |
| Dividend Yield | - |
| Shares Outstanding | 37.97M |
| Average Volume (1 week) | 61.5k |
| Average Volume (1 Month) | 115.98k |
| 52 Week Change | -26.38% |
| 52 Week High | 2.03 |
| 52 Week Low | 0.84 |
| Spread (Intraday) | 0.03 (2.52%) |
| Company Name | Bolt Biotherapeutics Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.boltbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
